Skip to content

Clinical trials

Phase 3 Gastrointestinal Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Diseases Phase: Phase 3 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20112
20161
20181
20211
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
InDex Pharmaceuticals2
Zealand Pharma2
Innovent Biologics (Suzhou) Co. Ltd.1
Pfizer1
Sumitomo Pharma America, Inc.1
University Hospital, Bordeaux1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Diseases10
Digestive System Diseases5
Intestinal Diseases5
Colorectal Neoplasms3
Digestive System Neoplasms3
Gastrointestinal Neoplasms3
Intestinal Neoplasms3
Neoplasms by Site3
Rectal Diseases3
Colitis, Ulcerative2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.